SNY
Sanofi
B-
65.1 / 100 composite
AlphaQuality composite grade, weighted for stable earnings power businesses.
-
5yr Avg ROIC
7.2%
-
Operating Margin Trend
-0.91 pp/yr
-
5yr Avg ROE
9.3%
-
5yr Share-Count CAGR
-0.6%
-
5yr Revenue CAGR
4.5%
-
5yr EPS CAGR
6.5%
-
Revenue-Growth Years (5)
5/5
-
5yr FCF Margin
19.6%
-
5yr FCF/NI Conversion
1.26x
-
Net Debt / EBITDA
0.95x
-
Interest Coverage (EBIT/Int)
10.86x
-
Altman Z-Score
1.62
Stability
Weight: 15%
B-
63
-
EPS Volatility (σ/μ)
0.42
-
Piotroski F-Score
6
-
Negative-Revenue Years (5)
0/5
Not enough curated-guru data to call a flow.